By Beth Ehrgott, page 1
This week, we continue our interview with Mike Bonney. As former CEO and Director of Cubist Pharmaceuticals culminating in the company’s acquisition by Merck for $9.4 billion, Mr. Bonney divides his time serving as board chair or board member of numerous biopharma companies and top academic institutions, giving a tremendous amount back to the greater community, as well as advising the next generation of leaders.
Beth Ehrgott, a colleague at our sister firm ...
Mike Bonney is one of the most highly respected executives in the biopharmaceutical industry. As former CEO and Director of Cubist Pharmaceuticals, he grew the company into a global leader in antibiotics, culminating in the company’s acquisition by Merck for $9.4 billion in 2014. Today, Mr. Bonney serves as board chair or board member of several biopharma companies and top academic institutions, and supports the community through not-for-profit leadership roles and contributions. Throughout ...
Background checks, especially at the executive level, are a necessary and integral part of the recruiting process. Why necessary? We uncover a surprising number of skeletons lurking, from unpaid tickets and bad credit to "misstatements" on candidate's bios and resumes (resumes that have often taken these candidates far in their careers).MORE >
Some of these skeletons prove enough to disqualify a candidate: Years ago, a background check for a public company board search revealed that ...
While it is exciting to step into a new role with a new organization, it can also be challenging and stressful as you navigate uncharted territory. The days of long honeymoon periods are gone, so read on for some suggestions to help you springboard into your new job.
1. Get a running start
Before showing up for the first day of work, be ready to hit the ground running. Do as much "pre-work" as you ...